Identification of a pathogenic NHLRC1 variant in a consanguineous Pakistani family affected with severe and rapidly progressive Lafora disease. [PDF]
Aslam Z +4 more
europepmc +1 more source
SINEUP-Mediated Overexpression of Endogenous α-Amylase as a Therapeutic Approach in Lafora Disease. [PDF]
Allegri L +8 more
europepmc +1 more source
Trehalose Treatment in Zebrafish Model of Lafora Disease. [PDF]
Della Vecchia S +11 more
europepmc +1 more source
Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for the Lafora Form of Progressive Myoclonus Epilepsy. [PDF]
Moreno-Estellés M +9 more
europepmc +1 more source
Gene therapy for Lafora disease in the Epm2a<sup>-/-</sup> mouse model. [PDF]
Zafra-Puerta L +10 more
europepmc +1 more source
Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity. [PDF]
Gumusgoz E +13 more
europepmc +1 more source
Drug-Resistant Early-Onset Progressive Myoclonic Epilepsy Revealing Lafora Disease: A Case Report. [PDF]
Pejanovic-Skobic N +5 more
europepmc +1 more source
An astrocytic cellular model of Lafora disease to study polyglucosan accumulation and inflammation. [PDF]
Moreno-Estellés M +7 more
europepmc +1 more source
Glycogenin-1 deficiency: a case report and review of the literature. [PDF]
Molitierno N +12 more
europepmc +1 more source
Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice. [PDF]
Zafra-Puerta L +7 more
europepmc +1 more source

